Skip to main content
Premium Trial:

Request an Annual Quote

AAM Proposes Initiative to Boost Genome Annotation

NEW YORK, Jan. 24 (GenomeWeb News) - The American Academy of Microbiology has issued a report proposing steps that can help overcome the challenge of annotating the numerous genomes that have been sequenced over the past decade, the group said today.

 

According to the AAM, it is recommending that a centralized genome annotation initiative be established in the US. The proposed initiative would include "a centrally organized database of peer-reviewed, experimentally verified gene annotations tied to catalogs of genes that have yet to be annotated and known biochemical functions for which a gene has yet to be found," the AAM said.

 

The AAM also said that a lack of available funding is a primary reason progress in genomic annotation has been slow, and that the annotation initiative provide flexible funding to support experiments in the field.

 

A full copy of the AAM's report, entitled "An Experimental Approach to Genome Annotation," along with its recommendations, can be found here.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.